ABOUT CONFERENCE

Conference Series Ltd organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Conference Series Ltd is an outstanding organization that organizes highly notable global roundup of Pharmaceutical Conferences . It’s glad to oraganize “9th World Congress on Bioavailability and Bioequivalence” (BABE 2018) in UAE on March 19-21, 2018 at Dubai after a similar series of conferences in consecutive years at USA over the last several years which met with great achievement in Business Conferencing.

This unique international conference will opportunity to reach the largest assemblage of participants from the Pharmaceutical community to gather and share their insights and convey recent developments in the field of generic drug research and current challenges and possibilities in modelling a new drug and breakthroughs in drug development, Generic drug safety, Novel trends and advanced strategies involving bioavailability bioequivalence research. This is a true forum where ideas and discussion is driven by the participants and interaction with peers and others leads to fruitful outcomes.
BABE 2018 is a 3-day event offering the Exhibition, at venue to showcase the new and emerging technologies and have wider sessions involving Keynote presentation, Oral, YRF ( student presentation), poster, e-poster presentations. World-renowned speakers and eminent delegates across the globe attending the conference, to share their valuable presentation on the most recent and advanced techniques, developments, and the newest updates are the prominent features of the conference.

Who to attend:
  • CEOs, CROs, Directors, Managers and research associates in pharmaceutical industry in the drug or device industries (both innovator and generic)
  • Academic and Industrial Scientists Associated with Discovery, Formulation and The Delivery of Drugs
  • Regulatory and Clinical Scientists Involved In Drug Development
  • Researchers, Education providers In Clinical Pharmacy, Pharmacology and Toxicology
  • Students and Postdoctoral Fellows In All Areas of The Pharmaceutical Sciences
  • Government Agencies Involved In Chemical Safety Assessment
  • Medical Practitioners Such As Clinical Pharmacologists, Clinical Toxicologists.
  • Molecular and Cellular Pharmacologists

CONFERENCE HIGHLIGHTS


  • Drug Design and development: Challenges
  • BA Studies and Assessment
  • Drug Metabolism
  • BE Studies and Assessment
  • Pharmacology- PK & PD approach
  • Pharmaceutical Formulations
  • Clinical Research Vs Clinical Trails
  • BCS & IVIVC Based Biowaivers
  • Biosimilars: Recent approches
  • Drug Safety: Pharmacovigilance Scope
  • Contract Research Organizations
  • Regulatory Requirements and Approaches
  • BA/BE Perspectives for Drug Products
  • Pharmaceutical Industry: Entrepreneur Meet